What's new

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Mar 7, 2025 - 13:57
 0
Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Kimberly Rossi Named General Manager for the Miraval Austin Resort & Spa

Next Article

The Duckhorn Portfolio adds drinks industry veterans to board

Related Posts

EMEA-003468-PIP01-23

EMEA-003468-PIP01-23

Feb 17, 2025  0

Combination of cystic fibrosis medicines to treat patients with rare mutations

Combination of cystic fibrosis medicines to treat patie...

Feb 28, 2025  0

Data Analysis and Real World Interrogation Network (DARWIN EU)

Data Analysis and Real World Interrogation Network (DAR...

Feb 20, 2025  0